These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 25128741)

  • 1. Role of microRNAs in the modulation of diabetic retinopathy.
    Mastropasqua R; Toto L; Cipollone F; Santovito D; Carpineto P; Mastropasqua L
    Prog Retin Eye Res; 2014 Nov; 43():92-107. PubMed ID: 25128741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of microRNAs in activating neovascularization pathways in diabetic retinopathy.
    Satari M; Aghadavod E; Mirhosseini N; Asemi Z
    J Cell Biochem; 2019 Jun; 120(6):9514-9521. PubMed ID: 30556195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered retinal microRNA expression profiles in early diabetic retinopathy: an in silico analysis.
    Xiong F; Du X; Hu J; Li T; Du S; Wu Q
    Curr Eye Res; 2014 Jul; 39(7):720-9. PubMed ID: 24502381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs: Potential Targets in Diabetic Retinopathy.
    Li X; Yu ZW; Wang Y; Fu YH; Gao XY
    Horm Metab Res; 2020 Mar; 52(3):142-148. PubMed ID: 32215885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-dependent cross-talk between VEGF and HIF1α in the diabetic retina.
    Ling S; Birnbaum Y; Nanhwan MK; Thomas B; Bajaj M; Ye Y
    Cell Signal; 2013 Dec; 25(12):2840-7. PubMed ID: 24018047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of miRNAs and long noncoding RNAs in the progression of diabetic retinopathy.
    Gong Q; Su G
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29074557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered microRNA expression profiles in retinas with diabetic retinopathy.
    Wu JH; Gao Y; Ren AJ; Zhao SH; Zhong M; Peng YJ; Shen W; Jing M; Liu L
    Ophthalmic Res; 2012; 47(4):195-201. PubMed ID: 22156553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of microRNAs in diabetes and its cardiovascular complications.
    Shantikumar S; Caporali A; Emanueli C
    Cardiovasc Res; 2012 Mar; 93(4):583-93. PubMed ID: 22065734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of long noncoding RNAs in early diabetic retinopathy.
    Yan B; Tao ZF; Li XM; Zhang H; Yao J; Jiang Q
    Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):941-51. PubMed ID: 24436191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA in the development of diabetic complications.
    McClelland AD; Kantharidis P
    Clin Sci (Lond); 2014 Jan; 126(2):95-110. PubMed ID: 24059587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA and diabetic retinopathy-biomarkers and novel therapeutics.
    Smit-McBride Z; Morse LS
    Ann Transl Med; 2021 Aug; 9(15):1280. PubMed ID: 34532417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs: the underlying mediators of pathogenetic processes in vascular complications of diabetes.
    Ruiz MA; Chakrabarti S
    Can J Diabetes; 2013 Oct; 37(5):339-44. PubMed ID: 24500562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatolactogens and diabetic retinopathy.
    Bermea KC; Rodríguez-García A; Tsin A; Barrera-Saldaña HA
    Growth Horm IGF Res; 2018 Aug; 41():42-47. PubMed ID: 29452885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-transcriptional gene regulation by HuR and microRNAs in angiogenesis.
    Chang SH; Hla T
    Curr Opin Hematol; 2014 May; 21(3):235-40. PubMed ID: 24714527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs: potential therapeutic targets in diabetic complications of the cardiovascular and renal systems.
    Figueira MF; Monnerat-Cahli G; Medei E; Carvalho AB; Morales MM; Lamas ME; da Fonseca RN; Souza-Menezes J
    Acta Physiol (Oxf); 2014 Jul; 211(3):491-500. PubMed ID: 24837225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives.
    Caldwell RB; Bartoli M; Behzadian MA; El-Remessy AE; Al-Shabrawey M; Platt DH; Caldwell RW
    Diabetes Metab Res Rev; 2003; 19(6):442-55. PubMed ID: 14648803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic retinopathy: neuron protection as a therapeutic target.
    Zhang X; Wang N; Barile GR; Bao S; Gillies M
    Int J Biochem Cell Biol; 2013 Jul; 45(7):1525-9. PubMed ID: 23506699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between miRNAs expression and signaling pathways of oxidative stress in diabetic retinopathy.
    Satari M; Aghadavod E; Mobini M; Asemi Z
    J Cell Physiol; 2019 Jun; 234(6):8522-8532. PubMed ID: 30478922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Correlation Between MicroRNAs and Diabetic Retinopathy.
    Zhao X; Ling F; Zhang GW; Yu N; Yang J; Xin XY
    Front Immunol; 2022; 13():941982. PubMed ID: 35958584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence.
    Simó R; Hernández C
    Prog Retin Eye Res; 2015 Sep; 48():160-80. PubMed ID: 25936649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.